title: Chemotherapy in nasopharyngeal carcinoma: review of results at University Hospital, Kuala Lumpur.
abstract: Nasopharyngeal carcinoma (NPC) is one of the commonest presentation of head and neck cancers in Malaysia, especially in the Chinese. The standard treatment is radical radiotherapy to the post-nasal space and the neck. Chemotherapy is given to patients with primary advanced disease and to patients with recurrence. The study reviews results of chemotherapy given to 33 patients at the University Hospital, Kuala Lumpur, over the last four years.
authors.forename: V K
authors.initials: VK
authors.lastname: Khanijow
authors.forename: U
authors.initials: U
authors.lastname: Prasad
authors.forename: C M
authors.initials: CM
authors.lastname: Chang
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use; D009303:Nasopharyngeal Neoplasms / Q000188:drug therapy* / Q000556:secondary; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D008727:Methotrexate